Scopolamine withdrawal syndrome.
As travel by air and ship becomes increasingly popular, more and more travelers are using transdermal scopolamine to avoid motion sickness. In fact, it has become almost fashionable for ocean travelers to sit on the sun deck with a patch behind the ear. This article describes withdrawal symptoms in a patient who used transdermal scopolamine beyond the recommended 3 days.
Saxena
K
K
Department of Emergency Medicine, St. Paul-Ramsey Medical Center, MN 55101.
Saxena
S
S
D000279:Administration, Cutaneous; D005260:Female; D006801:Humans; D008875:Middle Aged; D009041:Motion Sickness / Q000517:prevention & control; D010292:Paresthesia / Q000139:chemically induced*; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome; D013546:Sweating / Q000187:drug effects*; D013997:Time Factors; D014195:Travel
D012601:Scopolamine